TuHURA Biosciences Inc Sustainability Reports
TuHURA Biosciences Inc. is a Phase 3 clinical-stage immuno-oncology company that develops novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001V0HK36
1 reports from 2022 to 2022
Company Profile
TuHURA Biosciences Inc. is a Phase 3 clinical-stage immuno-oncology company that develops novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years